Stock performance and recent context Suzhou Ribo Life Science (SEHK:6938) has drawn investor attention after mixed recent returns, with the stock flat over the past day, slightly higher over the past ...

The consensus estimate for Q1 2026 revenue is $10.44 million, and the earnings are expected to come in at -$0.16 per share. The full year 2026's revenue is expected to be $59.96 million and the ...

China behind only US and UK in ranking, reflecting the country’s ‘major scale’ in AI, biotechnology and talent, says Deep ...

Achieve Life Sciences (ACHV) is scheduled to announce Q1 earnings results on Tuesday, May 12th, before market open. The ...

Life sciences executives are confronting a pivotal juncture in commercial strategy. The pharmaceutical and medical technology ...

I now feel confident that I can apply to any job and I will be seen as a strong candidate. When I graduate Bioversity, I very ...

The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

Each awardee was recognized for contributions to the animal science industry and research, as well as to the Department of Animal Science in the Dale Bumpers and the U of A System Division of ...

LifeSci Global Launches as Reliance’s Life Sciences Platform, Partnering with Scott Korman and David Turner as Its Founding Operator-Partners to Build, Lead and Grow the Platform ...

It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...

The president of the Back Bay real estate investment trust BXP said “there’s no question” that demand for life sciences lab ...